Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy

J Diabetes Investig. 2021 Aug;12(8):1322-1325. doi: 10.1111/jdi.13480. Epub 2021 Jan 14.

Abstract

Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.

Keywords: Diabetes retinopathy; Epidemiology; Risk factors; Screening; Treatment.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Diabetes Mellitus / epidemiology
  • Diabetic Retinopathy / diagnosis
  • Diabetic Retinopathy / epidemiology*
  • Diabetic Retinopathy / therapy*
  • Humans
  • Mass Screening
  • Prevalence
  • Risk Factors

Substances

  • Biomarkers